LPAR2 and neoplasm: More recently, LPA has been shown to protect tumor cells against apoptosis induced by radiotherapy or chemotherapy, mainly by interacting with LPA2, which results in depleting the cell of Siva-1 (a proapoptotic signaling protein) and in stimulating prosurvival pathways through a TRIP-6-mediated mechanism [68].